An alpha-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes

CLINICAL AND EXPERIMENTAL MEDICINE

SPRINGER

1. Ministry of Education, Cultures, Sports, Science and Technology, Japan